The Effect of Balance-focused Exercise Programme in Enhancing the Solus-muscle Activation During Gait Initiation for People With Parkinson Disease

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMinistry of Health, Kuwait

About this trial

Gait initiation (GI) is a crucial component of walking that requires a balanced muscle activity and postural stability. GI could be challenging for people with neurological condition such as people with Parkinson (PWP), where GI is usually impaired. The purpose of this study is determining effectiveness of comprehensive, balanced-focused exercise programme in controlling the activation of Solus-muscle in people with Parkinson disease. We hypothesise that balance-focus exercise programe could improve Solus-muscle activation during GI.

study type: this is a parallel group prospective (10 weeks) randomised single-blinded controlled trial conduct in Kuwait.

Participant: People with Parkinson, who met the inclusion criteria.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

participants diagnosed by their neurologist with Parkinson's disease (moderate to severe stage)

stable on anti-Parkinson's drugs

able to walk independently without a frame or walking stick.

Able to walk for more than 10 mins unaided

Disqualifiers

are pregnant

cardiac problems exacerbated by exercise

currently complaining of joint or muscle problems that affect walking ability

known to have neurological conditions (other than Parkinson) that affect walking ability

Trial design

Design model

Parallel

Treatments tested in this trial

  • balance-focus exercise programe

    Other intervention

    participants in the experimental group will receive balance-focused exercise programe integrated into conventional physiotherapy programe provided to people with parkinson.

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: control groupNo intervention 0 interventions
Group B: intervention (treatment ) groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

weight

weight of the person in KG

Time frame
baseline
2

height

the height of the person in CM

Time frame
baseline
3

gait analysis

• Three-dimensional motion analysis:Motion capture units will track the movement of reflective markers placed on the skin/clothing of participants.

Time frame
baseline
4

Gait Analysis

Three-dimensional motion analysis: Motion capture units will track the movement of reflective markers placed on the skin/clothing of participants.

Time frame
6 weeks

Secondary outcomes

1

Parkinson severity scale (PDQ-39)

To evaluate the impact of Parkinson's disease on different dimensions of a patient's life and monitor changes over time.

Time frame
baseline
2

Parkinson severity scale PDQ-39

To evaluate the impact of Parkinson's disease on different dimensions of a patient's life and monitor changes over time.

Time frame
6 weeks
3

Parkinson severity scale PDQ-39

To evaluate the impact of Parkinson's disease on different dimensions of a patient's life and monitor changes over time.

Time frame
10 weeks
4

Timed Up and Go test (TUG)

widely used clinical test to assess a person's mobility, balance, walking ability, and fall risk. It is especially useful in older adults and individuals with neurological or musculoskeletal impairment

Time frame
baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: